Showing results (311-320 of 387) with videos related to

Sort By:
Pageof 39
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 5, 2015
Time to Response to Citalopram Treatment for Agitation in Alzheimer DiseaseDaniel Weintraub, Lea T Drye, Anton P Porsteinsson, et al.
Research Square|October 7, 2024
α-Synuclein Conformations in Plasma Distinguish Parkinson's Disease from Dementia with Lewy BodiesGeorge T Kannarkat, Rebecca Zack, R Tyler Skrinak, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
α-Synuclein Conformations in Plasma Distinguish Parkinson's Disease from Dementia with Lewy BodiesGeorge T Kannarkat, Rebecca Zack, R Tyler Skrinak, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2019
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's diseaseBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.
JAMA|February 20, 2014
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trialAnton P Porsteinsson, Lea T Drye, Bruce G Pollock, et al.
Annals of Clinical and Translational Neurology|October 27, 2020
Tau pathology associates with in vivo cortical thinning in Lewy body disordersNicola Spotorno, David G Coughlin, Christopher A Olm, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2014
People with Parkinson's disease and normal MMSE score have a broad range of cognitive performanceDaniel J Burdick, Brenna Cholerton, G S Watson, et al.
The American Journal of Psychiatry|April 2, 2016
Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD StudyAnne K Leonpacher, Matthew E Peters, Lea T Drye, et al.
Annals of Neurology|June 16, 2025
Blood α-Synuclein Separates Parkinson's Disease from Dementia with Lewy BodiesGeorge T Kannarkat, Rebecca Zack, R Tyler Skrinak, et al.
Pageof 39